Shenzhen Capchem Technology Co (300037) Fair Value & Analysis
Basic Materials · CN · Market cap 57.3B CNY
Analysis
Shenzhen Capchem Technology Co (300037) currently trades at ¥89.99, while our model-based Fair Value estimate is ¥19.18 — implying the stock looks roughly 78.7% overvalued today. We read business quality at 89/100 (high quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
About the company
Shenzhen Capchem Technology Co., Ltd., together with its subsidiaries, engages in the research, development, production, sale, and service of new electronic chemicals and functional materials in China and internationally. It operates through three segments: Battery Chemicals, Organofluorine Chemicals, and Electronic Information Chemicals. The company offers battery chemicals, such as electrolytes for secondary lithium-ion batteries; electrolytes for primary lithium batteries; electrolytes for electric double-layer capacitors; emerging electrolytes and auxiliary materials; lithium salts, solvents, and additives. It also provides capacitor chemicals, including aluminum foil chemicals; liquid capacitive chemicals and electrolytes; chemicals for solid-state capacitors; chemicals for MLPC and tantalum capacitor; and capacitor sealing materials. In addition, the company offers semiconductor chemicals comprising etchants, strippers, high purity reagents, cleaners, coolant, and fluorinated …
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.